Adherence
Early weight loss (e.g., >= 5% at 3-4 months) is a strong predictor of sustained long-term weight loss across various obesity interventions, including pharmacotherapy and lifestyle modification.
Use the first 3-4 months of any obesity treatment as a critical checkpoint. If you haven't lost at least 5% of your body weight by then, it's a strong signal that the current plan may not work for you long-term. Discuss this with your provider to adjust the strategy rather than continuing a failing approach.
The most reliable predictors appear to be degree of adherence to the intervention, and early weight loss as a predictor of later or sustained weight loss (which is important to consider when determining whether to continue therapy).
Why this rating
Supported by multiple RCTs and pooled analyses across different drug classes and lifestyle programs.
Source
Precision medicine in adult and pediatric obesity: a clinical perspective
Eric M. Bomberg et al. · Therapeutic Advances in Endocrinology and Metabolism · 2019
DOI 10.1177/2042018819863022
More from this paper
- Person-specific characteristics (genetic, hormonal, psychosocial, and behavioral) significantly predict individual variability in weight loss response to obesity interventions, making precision medicine strategies potentially more effective than broad application of treatments.Good
- Higher baseline levels of inflammation (indicated by insulin, IL-6, adipose tissue inflammation, cortisol, and leptin) are associated with a worse weight loss response to lifestyle modification therapy.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →